Invention Grant
- Patent Title: Method of administration of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia
-
Application No.: US14126499Application Date: 2012-06-20
-
Publication No.: US09610287B2Publication Date: 2017-04-04
- Inventor: René Holm , Lone Bruun
- Applicant: René Holm , Lone Bruun
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Agency: Morgan, Lewis & Bockius, LLP
- Priority: DK201100465 20110620
- International Application: PCT/EP2012/061779 WO 20120620
- International Announcement: WO2012/175531 WO 20121227
- Main IPC: A61K31/495
- IPC: A61K31/495 ; A61K31/5513 ; A61K31/4545 ; A61K31/554 ; A61K31/496 ; A61K31/4515 ; A61K31/454 ; A61K31/517 ; A61K31/519
Abstract:
The present invention relates to 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and the salts thereof with activity at dopamine D1 and D2 receptors as well as the serotonin 5HT2 receptor for the treatment of diseases in the central nervous system in a once weekly dosing regime.
Public/Granted literature
Information query
